Who
David Paul Keenan
EVP, Chief Operating Officer
Company insider
Files Form 4 as: EVP, Chief Operating Officer, Amarin Corporation.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Jan 2026
- Last trade
- 1 Jul 2026
- Last filed
- 15 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —3,688 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $31K1,926 at $15.94 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,688 at $0.00 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,688 at $0.00 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —3,688 | filing |
| 1 Jul 2026filed 15 Jul 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $31K1,926 at $15.94 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,013 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,060 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,013 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,060 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —2,246 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $18K1,173 at $15.42 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —1,933 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,246 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,933 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $16K1,010 at $15.42 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,246 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,933 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —2,246 | filing |
| 31 Jan 2026filed 3 Feb 2026 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $18K1,173 at $15.42 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.